Press release
Us Polycystic Ovarian Syndrome Treatment Market Set to Cross US$ 313.2 Mn during 2016-2024
Also, therapies for diseases associated with PCOS are being developed to bear out the unmet clinical needs of people suffering from such complications. Despite this, the demand for PCOS treatment continues to incur a sluggish growth across the US. Persistence Market Research’s recent publication estimates that the US$ 230 Mn PCOS treatment market in the US will exhibit a moderate value CAGR of 3.9% to reach US$ 313.2 Mn by the end of 2024.
Read Report Overview @ https://www.persistencemarketresearch.com/market-research/us-polycystic-ovarian-syndrome-treatment-market.asp
The foremost growth inhibitor for polycystic ovary syndrome treatment market in the US is pending approval of drugs at the FDA. The US FDA continues to prolong the approval for drugs on polycystic ovary syndrome treatment. And, this has severely lowered the production of effective medicines, thereby impacting the adoption of PCOS treatment. Presently, no drugs have been approved by the FDA for direct treatment of PCOS. Physicians are thus providing drug prescriptions through off-label indications, which is incidentally diverting patients to generic drugs.
Titled as “Polycystic Ovary Syndrome Treatment Market: US Industry Analysis and Forecast, 2016-2024,” the report projects that in 2016, more than US$ 66 Mn worth of oral contraceptive drugs were consumed in the US polycystic ovary syndrome treatment market.
Through 2024, oral contraceptives will be exhibiting a steady revenue growth at 5.3% CAGR, and will account for nearly one-third share of market value. Besides, the demand for insulin sensitizing agents is expected to close in on number of oral contraceptives consumed in the US PCOS treatment market during this forecast period. Furthermore, growing preference to advanced drugs will also boost the consumption of aromatase inhibitors & SERMs, revenues from which will reach US$ 49 Mn by 2024-end.
Request Sample Report@ https://www.persistencemarketresearch.com/samples/14317
More than 47% of US polycystic ovary syndrome treatment market will be accounted by drug sales through hospital pharmacies. With hospitals as the largest distribution channel, nearly US$ 150 Mn worth of PCOS drugs will be sold through these pharmacies. Meanwhile, PCOS drug sales through e-commerce platforms are projected to showcase a value CAGR of 4.6%, higher than that of hospital pharmacies and other distribution channels such as fertility clinics, drug stores and over-the-top counters.
Key companies partaking in the growth of the US polycystic ovary syndrome treatment market include Sanofi, Novartis AG, Merck KGaA, Teva Pharmaceutical Industries Limited, and AstraZeneca plc.
Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/market-research/us-polycystic-ovarian-syndrome-treatment-market/toc
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Us Polycystic Ovarian Syndrome Treatment Market Set to Cross US$ 313.2 Mn during 2016-2024 here
News-ID: 970980 • Views: …
More Releases from Persistence Market Research
Pedestrian Entrance Control Systems Market Projected to Reach USD 3.3 Billion by …
Overview of the Market
The Pedestrian Entrance Control Systems (PECS) market is poised for substantial growth over the coming years, driven by the increasing demand for secure and efficient access management solutions in commercial, residential, and industrial sectors. These systems are critical for controlling pedestrian flow while ensuring safety and compliance with security protocols. The market is witnessing rapid adoption due to rising urbanization, advancements in biometric and smart access technologies,…
Digital Signature Market Anticipated to Hit USD 38.5 Billion by 2032
Overview of the Digital Signature Market
The global digital signature market is poised for remarkable growth, estimated to increase from US$ 8.4 billion in 2025 to US$ 38.5 billion by 2032, reflecting a robust CAGR of 25.8% during the forecast period. This surge is driven by the escalating demand for secure and efficient digital transaction solutions across industries such as BFSI, healthcare, government, and IT. Organizations are increasingly embracing digital signatures…
Family/Indoor Entertainment Centers Market Estimated to Grow at 11.9% CAGR by 20 …
Overview of the Market
The global family/indoor entertainment centers market is experiencing remarkable growth, fueled by increasing consumer demand for recreational and leisure activities. Estimated at US$ 46.8 billion in 2025, the market is projected to nearly double, reaching US$ 102.8 billion by 2032, registering a robust CAGR of 11.9% during the forecast period. Families and young adults are increasingly seeking immersive and interactive entertainment experiences, driving the popularity of indoor…
5G Network Equipment Market Anticipated to Hit USD 101,824.3 Million by 2032: Pe …
Overview of the Market
The global 5G network equipment market is set to experience exponential growth, with its size projected to rise from US$ 26,370.5 million in 2025 to US$ 101,824.3 million by 2032, reflecting a robust CAGR of 21.3% during the forecast period. The increasing need for ultra-fast wireless communication, low latency, and high network efficiency is driving the demand for 5G network infrastructure worldwide. Mobile operators and enterprises are…
More Releases for PCOS
Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728
Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis…
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this…
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,…
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with…
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy
PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.…
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness.
Get Free Sample Research Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10043
PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms…
